Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
Background: Diabetes mellitus is associated with an increased risk of restenosis, stent thrombosis, and death afterpercutaneous coronary interventions. Little is known about the late outcome of patients with diabetes mellitus whoreceive drug-eluting stents (DES) or bare metal stents (BMS).Methods: F...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Electronic Physician
2011-06-01
|
| Series: | Electronic Physician |
| Subjects: | |
| Online Access: | http://ephysician.ir/2011/409-413.pdf |
| _version_ | 1811276092236890112 |
|---|---|
| author | Kakhaber Etsadashvili Khatuna Jalabadze Georgi Getmansky Irakli Davitashvili Ia Avaliani Mynuddin Ahmed Nawaz |
| author_facet | Kakhaber Etsadashvili Khatuna Jalabadze Georgi Getmansky Irakli Davitashvili Ia Avaliani Mynuddin Ahmed Nawaz |
| author_sort | Kakhaber Etsadashvili |
| collection | DOAJ |
| description | Background: Diabetes mellitus is associated with an increased risk of restenosis, stent thrombosis, and death afterpercutaneous coronary interventions. Little is known about the late outcome of patients with diabetes mellitus whoreceive drug-eluting stents (DES) or bare metal stents (BMS).Methods: From January 2008 to January 2010, six patients with DES and 20 with BMS, ISR were identified at ourinstitution.Results: The median age of our diabetic cohort was 63 years, and 87 of the patients were male. For two years, ratesof repeat target-vessel revascularization were significantly lower among diabetic patients treated with DEScompared with those treated with BMS (5.8% vs. 17.0%, p=0.003).Conclusions: DES is effective among diabetic patients in substantially reducing the need for repeat TVR. |
| first_indexed | 2024-04-12T23:50:12Z |
| format | Article |
| id | doaj.art-6bfa3efe04914fe3af024a25effe31a0 |
| institution | Directory Open Access Journal |
| issn | 2008-5842 |
| language | English |
| last_indexed | 2024-04-12T23:50:12Z |
| publishDate | 2011-06-01 |
| publisher | Electronic Physician |
| record_format | Article |
| series | Electronic Physician |
| spelling | doaj.art-6bfa3efe04914fe3af024a25effe31a02022-12-22T03:11:43ZengElectronic PhysicianElectronic Physician2008-58422011-06-0134409413Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among DiabeticsKakhaber EtsadashviliKhatuna JalabadzeGeorgi GetmanskyIrakli DavitashviliIa AvalianiMynuddin Ahmed NawazBackground: Diabetes mellitus is associated with an increased risk of restenosis, stent thrombosis, and death afterpercutaneous coronary interventions. Little is known about the late outcome of patients with diabetes mellitus whoreceive drug-eluting stents (DES) or bare metal stents (BMS).Methods: From January 2008 to January 2010, six patients with DES and 20 with BMS, ISR were identified at ourinstitution.Results: The median age of our diabetic cohort was 63 years, and 87 of the patients were male. For two years, ratesof repeat target-vessel revascularization were significantly lower among diabetic patients treated with DEScompared with those treated with BMS (5.8% vs. 17.0%, p=0.003).Conclusions: DES is effective among diabetic patients in substantially reducing the need for repeat TVR.http://ephysician.ir/2011/409-413.pdfDiabeticsBare metal stents (BMS)Drug eluting stents (DES)In-stent restenosis (ISR)Target Vessel Revascularization (TVR). |
| spellingShingle | Kakhaber Etsadashvili Khatuna Jalabadze Georgi Getmansky Irakli Davitashvili Ia Avaliani Mynuddin Ahmed Nawaz Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics Electronic Physician Diabetics Bare metal stents (BMS) Drug eluting stents (DES) In-stent restenosis (ISR) Target Vessel Revascularization (TVR). |
| title | Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics |
| title_full | Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics |
| title_fullStr | Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics |
| title_full_unstemmed | Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics |
| title_short | Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics |
| title_sort | comparison of bare metal vs drug eluting stents for in stent restenosis among diabetics |
| topic | Diabetics Bare metal stents (BMS) Drug eluting stents (DES) In-stent restenosis (ISR) Target Vessel Revascularization (TVR). |
| url | http://ephysician.ir/2011/409-413.pdf |
| work_keys_str_mv | AT kakhaberetsadashvili comparisonofbaremetalvsdrugelutingstentsforinstentrestenosisamongdiabetics AT khatunajalabadze comparisonofbaremetalvsdrugelutingstentsforinstentrestenosisamongdiabetics AT georgigetmansky comparisonofbaremetalvsdrugelutingstentsforinstentrestenosisamongdiabetics AT iraklidavitashvili comparisonofbaremetalvsdrugelutingstentsforinstentrestenosisamongdiabetics AT iaavaliani comparisonofbaremetalvsdrugelutingstentsforinstentrestenosisamongdiabetics AT mynuddinahmednawaz comparisonofbaremetalvsdrugelutingstentsforinstentrestenosisamongdiabetics |